RESEARCH AND DEVELOPMENT

We develop innovative products through analytical, preclinical and clinical research.

Product
development

We face the population health needs, through new products development that represent 10% of our annual sales investment.

Learn More
  • CANIFARMA recognition (2005) In the Technological Research/Innovation category
  • Mexican Council for Science & Technology (COMECYT, by its Spanish acronym) (2008) Award in the Technology category.
  • Mexican Association of Directors of Applied Research and Technological Development (ADIAT, by its Spanish acronym) Award (2009) For its Technological Innovation
  • Tecnos 2009 Award In the category of Technological Products
Learn More

Clinical studies

The main objective of our clinical studies is to establish the safety and efficacy of the products we develop and sell, meeting the highest quality standards.

Pharmaceutical Products Division
  • Hypertension
  • Metabolic syndrome
  • Anti tuberculosis
  • Vitamins
  • Pain
  • Antiparasitic
  • Asthma preventative and others
Biotechnological Division
  • Ocular diseases.
  • Inflammatory diseases.
  • Neurodegenerative diseases.
  • Autoimmune diseases.
  • Infectious diseases.
  • Diabetes.
Diagnostic Division
  • Detection of HIV antibodies in serum or plasma through the HIV-Instantest.
  • Detection of anti-Trypanosoma cruzi antibodies to diagnose the Chagas disease.
Learn More

We provide life quality globally.

Our infrastructure, technology, processes and products are supported by high quality and safety standards.

We guarantee effective treatments in compliance with the requirements and good manufacturing practices, established in current regulations.

Product development
Medicines with the highest quality standards.
Clinical studies
We analyze and produce the best medicines.